Literature DB >> 8066489

Cost utility analysis: what should be measured?

J Richardson1.   

Abstract

The paper re-examines the issue of the appropriate unit for measuring output in cost utility analysis and the technique that will measure it. There are two main themes. The first is that utility, as it is often conceived and quantified, is not an appropriate basis for measurement. Consequently, a question arises concerning the selection of an appropriate unit of measurement. The second theme is that there is a need to establish criteria for the evaluation of measurement units. Four criteria are proposed which follow from commonly accepted social objectives and from the requirements of a measurement unit. It is concluded that, as judged by these criteria, the measurement units produced by the time trade-off and person trade-off (equivalence) techniques are more satisfactory than the units produced by the rating scale, magnitude estimation or the standard gamble.

Entities:  

Mesh:

Year:  1994        PMID: 8066489     DOI: 10.1016/0277-9536(94)90162-7

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  33 in total

Review 1.  Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?

Authors:  C Bombardier; A Maetzel
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off.

Authors:  X Badia; S Monserrat; M Roset; M Herdman
Journal:  Qual Life Res       Date:  1999-06       Impact factor: 4.147

3.  The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life.

Authors:  G Hawthorne; J Richardson; R Osborne
Journal:  Qual Life Res       Date:  1999-05       Impact factor: 4.147

Review 4.  Valuing health-related quality of life. A review of health state valuation techniques.

Authors:  C Green; J Brazier; M Deverill
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

5.  Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996).

Authors:  B George; A Harris; A Mitchell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

6.  Improving the sensitivity of the time trade-off method: results of an experiment using chained TTO questions.

Authors:  G C Morrison; A Neilson; M Malek
Journal:  Health Care Manag Sci       Date:  2002-02

Review 7.  Valuing health-related quality of life. Issues and controversies.

Authors:  P Dolan
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

8.  The effect of different methods of collecting data: mail, telephone and filter data collection issues in utility measurement.

Authors:  Graeme Hawthorne
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

9.  Using conjoint analysis and choice experiments to estimate QALY values: issues to consider.

Authors:  Terry N Flynn
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

10.  A Norwegian 15D value algorithm: proposing a new procedure to estimate 15D value algorithms.

Authors:  Yvonne Anne Michel; Liv Ariane Augestad; Mathias Barra; Kim Rand
Journal:  Qual Life Res       Date:  2018-11-30       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.